EU drug watchdog backs ‘medicines repurposing’ pilot
Medicines approved by the European Medicines Agency (EMA) to treat one illness could be repurposed by academics and non-governmental organisations as therapies for other illnesses, as part of […]
Medicines approved by the European Medicines Agency (EMA) to treat one illness could be repurposed by academics and non-governmental organisations as therapies for other illnesses, as part of […]
Treatment with alendronate, an osteoporosis drug, appears to reduce the risk of developing type 2 diabetes, researchers reported on Sept. 26, 2021 at the annual meeting of the […]
Immunotherapy with pembrolizumab after surgery significantly improves disease-free survival among patients with the most prevalent form of kidney cancer, clear-cell renal carcinoma. Researchers reported this finding on June […]
When treated with adjuvant olaparib after completion of local treatment and neoadjuvant or adjuvant chemotherapy, patients with high-risk, HER2-negative early breast cancer and germline BRCA1 or BRCA2 pathogenic or likely pathogenic variants, […]
With the outbreak of the Pandemic and the lingering worries of COVID-19 pharmaceutical sales and marketing has taken a hit. There are no live conferences that health care […]
A bacteriophage-loaded hydrogel proved to be effective treatment for a chronically infected knee prosthesis, according to Thomas Briot and colleagues (Red Cross Hospital, Lyon, France). Infection is one […]
The feasibility of 3D printing and using amiodarone tablets was explored by Ian Soulairol and colleagues at the University Hospital of Nîmes. Paediatric drug dosing presents challenges because […]
Storage of drug products at ultra-low temperatures calls for understanding of the special risks involved… Until recently cryopreservation for pharmaceutical products was only an issue for those dealing […]
ADVERTISMENT
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.